SS Innovations International (SSII) Liabilities and Shareholders Equity (2016 - 2026)

SS Innovations International's (SSII) quarterly Liabilities and Shareholders Equity came in at $90.5 million in Q1 2026, up 42.69% year-on-year from $63.5 million in Q1 2025, and up 21.99% quarter-over-quarter from $74.2 million in Q4 2025.

SS Innovations International (SSII) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

SS Innovations International has disclosed Liabilities and Shareholders Equity across 11 years of filings, most recently posting $90.5 million for Q1 2026.

  • Liabilities and Shareholders Equity for Q1 2026 came in at $90.5 million, up 42.69% year-over-year; the trailing twelve-month figure through Mar 2026 was $304.3 million (up 68.57% YoY), and the FY2025 annual result was $74.2 million, up 75.12% from the prior year.
  • Liabilities and Shareholders Equity came in at $90.5 million for Q1 2026 at SS Innovations International, up from $74.2 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $90.5 million in Q1 2026 to a low of $279336.0 in Q2 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $35.2 million (2024), against an average of $35.7 million.
  • Across the five-year window, Liabilities and Shareholders Equity tumbled 36.52% in 2022 and jumped 4349.77% in 2023, its largest moves.
  • SS Innovations International's Liabilities and Shareholders Equity stood at $7.0 million in 2022, then surged by 351.48% to $31.5 million in 2023, then jumped by 34.49% to $42.4 million in 2024, then soared by 75.12% to $74.2 million in 2025, then grew by 21.99% to $90.5 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $90.5 million (Q1 2026), $74.2 million (Q4 2025), and $69.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 110.43 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 46.29 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 37.13 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn 10.74 Bn
10 SS Innovations International 689.95 Mn 666.34 Mn 5.33 Mn 90.55 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.55 Mn
Dec 31, 2025 74.23 Mn
Sep 30, 2025 69.58 Mn
Jun 30, 2025 69.98 Mn
Mar 31, 2025 63.46 Mn
Dec 31, 2024 42.39 Mn
Sep 30, 2024 39.02 Mn
Jun 30, 2024 35.67 Mn
Mar 31, 2024 35.20 Mn
Dec 31, 2023 31.52 Mn
Sep 30, 2023 28.16 Mn
Jun 30, 2023 12.43 Mn
Mar 31, 2023 5.47 Mn
Dec 31, 2022 6.98 Mn
Sep 30, 2022 1.65 Mn
Jun 30, 2022 279,336.00
Mar 31, 2022 367,396.00
Dec 31, 2021 428,607.00
Sep 30, 2021 334,401.00
Jun 30, 2021 440,038.00